Investigating how HMGA1 proteins contribute to aggressive leukemia and treatment resistance
Role of the chromatin regulator HMGA1 in KMT2A-rearranged leukemia
This study is looking at how a protein called HMGA1 affects a tough type of leukemia called KMT2A-rearranged acute myeloid leukemia, with the goal of finding better treatment options for patients who often struggle with current therapies.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11161139 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of HMGA1 proteins in KMT2A-rearranged acute myeloid leukemia (AML), a severe form of leukemia that often does not respond to existing treatments. The study aims to uncover the mechanisms by which HMGA1 influences the development of leukemia and its resistance to therapies. By analyzing the behavior of HMGA1 in leukemia cells, researchers hope to identify new therapeutic strategies that could improve treatment outcomes for patients with this aggressive cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with KMT2A-rearranged acute myeloid leukemia who are experiencing treatment resistance.
Not a fit: Patients with other types of leukemia or those who do not have KMT2A rearrangements may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that are more effective for patients with KMT2A-rearranged AML.
How similar studies have performed: While there have been studies on KMT2A-rearranged leukemia, the specific focus on HMGA1 as a therapeutic target is a novel approach.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: West, Bailey — Johns Hopkins University
- Study coordinator: West, Bailey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.